Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182

Oncology Reports

Volumn 35, Issue 4, 2016, Pages 2461-2465

  Devor, Eric J ^a   Schickling, Brandon M ^a,b   Reyes, Henry D ^a   Warrier, Akshaya ^a   Lindsay, Brittany ^a,c   Goodheart, Michael J ^a,d   Santillan, Donna A ^a   Leslie, Kimberly K ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b Internal Medicine Residency Program   (United States)

^c LINCOLN UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Cullin 5; Methylation; miR 182; Ubiqutination

Indexed keywords

CULLIN 5; FAS LIGAND; JANUS KINASE 2; MICRORNA 182; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CUL5 PROTEIN, HUMAN; CULLIN; MICRORNA; MIRN182 MICRORNA, HUMAN;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DEMETHYLATION; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIUM CARCINOMA; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; TUMOR INVASION; UBIQUITINATION; 3' UNTRANSLATED REGION; DNA METHYLATION; DOWN REGULATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CARCINOMA, ENDOMETRIOID; CELL LINE, TUMOR; CELL PROLIFERATION; CULLIN PROTEINS; DNA METHYLATION; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION;

EID: 84959307086     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4605     Document Type: Article

References (26)

1. Petroski MD and Deshaies RJ:Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 6: 9-20, 2005.
2. Burnatowska-Hledin MA, Kossoris JB, Van Dort CJ, Shearer RL, Zhao P, Murrey DA, Abbott JL, Kan CE and Barney CC: T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene. Biochem Biophys Res Commun 319: 817-825, 2004.
3. Johnson AE, Le IP, Buchwalter A and Burnatowska-Hledin MA: Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene. Mol Cell Biochem 301: 13-20, 2007.
4. Xu XM, Wang XB, Chen MM, Liu T, Li YX, Jia WH, Liu M, Li X and Tang H: MicroRNA-19a and-19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett 322: 148-158, 2012.
5. Ma C, Qi Y, Shao L, Liu M, Li X and Tang H: Downregulation of miR-7 upregulates cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells. IUBMB Life 65: 1026-1034, 2013.
6. American Cancer Society Cancer facts & figures 2014. http://www. cancer.org/acs/groups/content/@research/documents/document/acspc-041770.pdf. Accessed February 10, 2014.
7. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et al, (eds): SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. Bethesda, MD, USA. http://seer.cancer.gov/csr/1975-2011/, based on November 2013 SEER data submission, posted to the SEER website, April 2014.
8. Devor EJ, Hovey AM, Goodheart MJ, Ramachandran S and Leslie KK: microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs. Oncol Rep 26: 995-1002, 2011.
9. Rapti SM, Kontos CK, Papadopoulos IN and Scorilas A: Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clin Chem Lab Med 52: 1217-1227, 2014.
10. Albitar L, Pickett G, Morgan M, Davies S and Leslie KK: Models representing type I and type II human endometrial cancers: Ishikawa H and Hec50co cells. Gynecol Oncol 106: 52-64, 2007.
11. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Methods 25: 402-408, 2001.
12. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative Ct method. Nat Protoc 3: 1101-1108, 2008.
13. Snedecor GW and Cochran WG: Statistical Methods. 8th edition. Iowa State University Press, Ames, IA, pp158-160, 1989.
14. Stanic B, Katsuyama M and Miller FJ Jr: An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol 30: 2234-2241, 2010.
15. Li LC and Dahiya R: MethPrimer: Designing primers for methylation PCRs. Bioinformatics 18: 1427-1431, 2002.
16. Hashimoto Y, Akiyama Y, Otsubo T, Shimada S and Yuasa Y: Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis 31: 777-784, 2010.
17. Burnatowska-Hledin M and Barney CC: New insights into the mechanism for VACM-1/cul5 expression in vascular tissue in vivo. Int Rev Cell Mol Biol 313: 79-101, 2014.
18. Burnatowska-Hledin M, Zhao P, Capps B, Poel A, Parmelee K, Mungall C, Sharangpani A and Listenberger L: VACM-1, a cullin gene family member, regulates cellular signaling. Am J Physiol Cell Physiol 279: C266-C273, 2000.
19. Van Dort C, Zhao P, Parmelee K, Capps B, Poel A, Listenberger L, Kossoris J, Wasilevich B, Murrey D, Clare P and Burnatowska-Hledin M: VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am J Physiol Cell Physiol 285: C1386-C1396, 2003.
20. Bradley SE, Johnson AE, Le IP, Oosterhouse E, Hledin MP, Marquez GA and Burnatowska-Hledin M: Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect. J Biol Chem 285: 4883-4895, 2010.
21. Zhang Y, Wang X, Wang Z, Tang H, Fan H and Guo Q: miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer. Oncol Rep 33: 2592-2598, 2015.
22. Li Y, Zhang D, Wang X, Yao X, Ye C, Zhang S, Wang H, Chang C, Xia H, Wang YC, et al: Hypoxia-inducible miR-182 enhances HIF1? signaling via targeting PHD2 and FIH1 in prostate cancer. Sci Rep 5: 12495, 2015.
23. Sun J, Ji J, Huo G, Song Q and Zhang X: miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. Int J Clin Exp Pathol 8: 4755-4763, 2015.
24. Liu S, Howell PM and Riker AI: Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. Ann Surg Oncol 20: 1745-1752, 2013.
25. Zhou MJ, Chen FZ and Chen HC: Ubiquitination-involved enzymes and cancer. Med Oncol 31: 93, 2014.
26. Yu H, Lee H, Herrmann A, Buettner R and Jove R: Revisiting STAT3 signalling in cancer: New and unexpected biological functions. Nat Rev Cancer 14: 736-746, 2014.